Pages that link to "Q28165369"
Jump to navigation
Jump to search
The following pages link to The calibrated automated thrombogram (CAT): a universal routine test for hyper- and hypocoagulability (Q28165369):
Displaying 50 items.
- Blood coagulation and the risk of atherothrombosis: a complex relationship (Q24808644) (← links)
- From principle to practice: bridging the gap in patient profiling (Q27318447) (← links)
- Thrombin generation by activated factor VII on platelet activated by different agonists. Extending the cell-based model of hemostasis (Q28196701) (← links)
- Recombinant factor VIIa reverses the inhibitory effect of aspirin or aspirin plus clopidogrel on in vitro thrombin generation (Q28200448) (← links)
- New synthetic thrombin inhibitors: molecular design and experimental verification (Q28744536) (← links)
- Novel methodology for assessment of prophylactic platelet transfusion therapy by measuring increased thrombus formation and thrombin generation (Q33373629) (← links)
- Prothrombin Complex Concentrates for Bleeding in the Perioperative Setting (Q33430766) (← links)
- Functional Assays in the Diagnosis of Heparin-Induced Thrombocytopenia: A Review (Q33440890) (← links)
- A new measure for in vivo thrombin activity in comparison with in vitro thrombin generation potential in patients with hyper- and hypocoagulability (Q33599937) (← links)
- Prediction of bleeding risk in patients taking vitamin K antagonists using thrombin generation testing (Q33637902) (← links)
- Moderate plasma dilution using artificial plasma expanders shifts the haemostatic balance to hypercoagulation. (Q33678363) (← links)
- Detection of endogenous tissue factor levels in plasma using the calibrated automated thrombogram assay (Q33679124) (← links)
- The hemostatic profile of recombinant activated factor VII. Can low concentrations stop bleeding in off-label indications? (Q33911771) (← links)
- An engineered factor Va prevents bleeding induced by anticoagulant wt activated protein C (Q34050588) (← links)
- Similar hypercoagulable state and thrombosis risk in type I and type III protein S-deficient individuals from families with mixed type I/III protein S deficiency (Q34095663) (← links)
- Cellular microparticle and thrombogram phenotypes in the Prospective Observational Multicenter Major Trauma Transfusion (PROMMTT) study: correlation with coagulopathy (Q34160603) (← links)
- Improved hemostasis in hemophilia mice by means of an engineered factor Va mutant (Q34165592) (← links)
- Self-titrating anticoagulant nanocomplexes that restore homeostatic regulation of the coagulation cascade. (Q34239129) (← links)
- Diesel engine exhaust initiates a sequence of pulmonary and cardiovascular effects in rats (Q34260730) (← links)
- The plasma hemostatic proteome: thrombin generation in healthy individuals (Q34481022) (← links)
- A single chain variant of factor VIII Fc fusion protein retains normal in vivo efficacy but exhibits altered in vitro activity (Q34557556) (← links)
- Antiplatelet agents can promote two-peaked thrombin generation in platelet rich plasma: mechanism and possible applications (Q34584420) (← links)
- Procoagulant activity, but not number, of microparticles increases with age and in individuals after a single venous thromboembolism (Q34788985) (← links)
- Bortezomib, C1-inhibitor and plasma exchange do not prolong the survival of multi-transgenic GalT-KO pig kidney xenografts in baboons (Q35012361) (← links)
- Arachidonate 15-lipoxygenase enzyme products increase platelet aggregation and thrombin generation (Q35095407) (← links)
- Characterization of an autosomal dominant bleeding disorder caused by a thrombomodulin mutation (Q35126279) (← links)
- Heparin and Protamine Titration Does Not Improve Haemostasis after Cardiac Surgery: A Prospective Randomized Study (Q35680961) (← links)
- Thrombin Generating Capacity and Phenotypic Association in ABO Blood Groups (Q35824093) (← links)
- Hypoxia Induces a Prothrombotic State Independently of the Physical Activity (Q35827039) (← links)
- The hypercoagulable profile of patients with stent thrombosis (Q35891856) (← links)
- Recombinant Factor IX Fc Fusion Protein Maintains Full Procoagulant Properties and Exhibits Prolonged Efficacy in Hemophilia B Mice (Q35913495) (← links)
- Current methods of assessing platelet function: relevance to transfusion medicine (Q36078677) (← links)
- Empirical and theoretical phenotypic discrimination (Q36090193) (← links)
- Thrombin generation and bleeding in haemophilia A (Q36090217) (← links)
- Mechanistic implications for the use and monitoring of recombinant activated factor VII in trauma (Q36284640) (← links)
- Anticoagulant properties of enoxaparin 400 IU/mL-40 % ethanol catheter lock solution (Q36338921) (← links)
- Decreased prothrombin conversion and reduced thrombin inactivation explain rebalanced thrombin generation in liver cirrhosis (Q36363182) (← links)
- Thrombography reveals thrombin generation potential continues to deteriorate following cardiopulmonary bypass surgery despite adequate hemostasis (Q36374584) (← links)
- New approaches for measuring coagulation. (Q36473061) (← links)
- Diagnostic approach to inherited bleeding disorders (Q36715734) (← links)
- State of the art in platelet function testing (Q36802971) (← links)
- Systems Analysis of Thrombus Formation (Q36855652) (← links)
- Tissue factor-dependent thrombin generation across pregnancy (Q36865746) (← links)
- The Alzheimer's disease peptide β-amyloid promotes thrombin generation through activation of coagulation factor XII. (Q36909451) (← links)
- Role of platelets, neutrophils, and factor XII in spontaneous venous thrombosis in mice (Q36942043) (← links)
- A new method to determine tissue specific tissue factor thrombomodulin activities: endotoxin and particulate air pollution induced disbalance (Q36942543) (← links)
- Low plasma levels of tissue factor pathway inhibitor in patients with congenital factor V deficiency. (Q36948563) (← links)
- Blood product support for delivery in severe factor X deficiency: the use of thrombin generation to guide therapy (Q36969491) (← links)
- Coagulation abnormalities of sickle cell disease: Relationship with clinical outcomes and the effect of disease modifying therapies. (Q37033939) (← links)
- The modification of the thrombin generation test for the clinical assessment of dabigatran etexilate efficiency. (Q37063974) (← links)